Overview of the Acquisition
RadNet, a prominent diagnostic imaging company, has acquired See-Mode Technologies, an AI ultrasound imaging firm, through its subsidiary DeepHealth. This strategic acquisition aims to enhance RadNet’s offerings in population health by integrating See-Mode’s advanced AI technology.
Key Features of See-Mode’s Technology
- AI-powered applications for detecting and characterizing thyroid nodules and breast lesions.
- Improves diagnostic accuracy and enhances clinical workflows by generating standardized reports.
Benefits of the Acquisition
Dr. Howard Berger, President and CEO of RadNet, highlighted several advantages:
- Early deployment of See-Mode’s FDA-approved thyroid ultrasound AI has shown a 30% reduction in scan time.
- The technology increases workflow efficiency through automated detection and reporting.
- With high demand for ultrasound services, See-Mode’s technology is expected to enhance access and revenue across RadNet’s imaging centers.
Industry Context
This acquisition aligns with broader trends in the healthcare sector:
- In 2024, GE HealthCare and DeepHealth collaborated on AI imaging technology to improve efficiency and collaboration in imaging.
- RadNet previously partnered with Volpara Health Technologies to deploy analytics software across its imaging centers.
- See-Mode received FDA clearance for its AI-powered thyroid ultrasound solution in 2024, following earlier approvals in Australia and New Zealand.
Conclusion
The integration of See-Mode’s technology into RadNet’s services is a significant step towards enhancing diagnostic capabilities in ultrasound imaging, ultimately aiming to improve patient care and operational efficiency.
